Enwei Pharmaceutical Co Ltd
SZSE:301331
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Enwei Pharmaceutical Co Ltd
SZSE:301331
|
CN |
|
I
|
Indofood Sukses Makmur Tbk PT
SWB:ISM
|
ID |
|
Nov Inc
NYSE:NOV
|
US |
|
H
|
Halliburton Co
XETRA:HAL
|
US |
|
M
|
Mitsui E&S Holdings Co Ltd
F:MU1
|
JP |
|
Advanced Info Service PCL
OTC:AVIFY
|
TH |
|
O
|
Onto Innovation Inc
XMUN:NNM
|
US |
|
Industrias Penoles SAB de CV
OTC:IPOAF
|
MX |
Intrinsic Value
Is Enwei Pharmaceutical Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Enwei Pharmaceutical Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Enwei Pharmaceutical Does
Enwei Pharmaceutical makes and sells medicines. Its business is centered on finished drug products, which it sells through hospital channels, pharmacies, and pharmaceutical distributors in China. For beginners, the key point is that this is a drug maker, not a drugstore or a healthcare service business: it turns pharmaceutical formulas into packaged medicines that patients buy with a prescription or over the counter.
- Headquarters
- China CN
- Employees
- 1 501
- IPO date
- Sep 21, 2022
Earnings Waterfall
Enwei Pharmaceutical Co Ltd
The intrinsic value for Enwei Pharmaceutical Co Ltd (301331) under the Base Case is hidden CNY.
Compared with the current market price of 22.75 CNY, the stock appears hidden.